HEALTH – “The risks of thrombosis are very low”, according to the American health authorities
American health authorities gave the green light on Friday to resume vaccination with Johnson & Johnson’s serum in the United States, suspended on April 13 after rare cases of thrombosis. “Use of Janssen’s Covid-19 vaccine is expected to resume in the United States,” the Centers for Disease Control and Prevention (CDC) and the US drug agency, the FDA, said in a statement. that the benefits of the vaccine outweighed the risks in people 18 years of age and older.
The break in the use of the vaccine developed by the American laboratory had been decided to investigate several cases of women who developed serious cases of blood clots in association with low levels of platelets after their injection. “The FDA and CDC are confident that this vaccine is safe and effective in preventing Covid-19,” the two agencies said. “For now, the available data suggests that the risk” of thrombosis “is very low, but the FDA and the CDC will remain vigilant and will continue to investigate this risk”, according to the text.
Three in 8 million deaths
Health personnel administering (…) Read more on 20minutes
You may also be interested in this content:
–
